Accession Number: | 0001209191-23-031453 |
Date: | 2023-05-18 |
Issuer: | CORBUS PHARMACEUTICALS HOLDINGS, INC. (CRBP) |
Original Submission Date: |
HOLMER ALAN F
C/O CORBUS PHARMACEUTICALS HOLDINGS, INC
500 RIVER RIDGE DRIVE
NORWOOD, MA 02062
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 9.96 | 2023-05-18 | deemed execution date | A | 5,300 (a) | 2033-05-18 | common stock 5,300 | $9.96 | 5,300 | direct |
ID | footnote |
---|---|
f1 | the annual option award was made in accordance with the terms of the issuer's 2014 equity compensation plan. the option will vest 100% on the one year anniversay from the date of grant. |